Calif. Prop 65 Warnings On Smoking Cessation Drugs Federally Preempted, Court Says
This article was originally published in The Pink Sheet Daily
Executive Summary
State-mandated warnings that OTC nicotine replacement therapies may "cause reproductive harm" directly conflict with FDA labeling requirements, California Supreme Court rules in a victory for drug manufacturers and the agency.
You may also be interested in...
Statin Carcinogenicity Data Could Be Reviewed By California In 2006
The state's Office of Environmental Health Hazard Assessment has received data on nearly all the drugs, including previously unpublished information. Requests to FDA have largely gone unanswered.
Fraud Discovery Institute Asks Waxman To Address Lead In Herbalife Products
FDA should issue a public health alert to warn consumers about potential health risks that may result from use of Herbalife dietary supplements and should remove the company's products from the market, pending further investigation of lead contamination, according to Christopher Grell, an attorney whose firm specializes in ephedra and dietary supplement litigation